💊 Get Daily Updates on Generic Entry, Litigation, Biosimilars, and More…
Profile for Esperion Therapeutics, Inc. (ESPR)
« Back to company indexESPR Chatter Timeline
Stock Ticker for ESPR
Most Active Tweeters for ESPR
| User | Tweets |
|---|---|
| @BPrasad93 | 15 |
| @PetterTrade | 10 |
| @Tickeron | 9 |
| @TradeWithAlerts | 9 |
| @mehabecapital | 6 |
Recent Tweets for ESPR
 |
@wyv_123 @puck_flastic @Benchpressers This week the only doubles we saw in biotech were in shares outstanding. $ESPR ?? 1:12am |
 |
@XBIObserver @Sanctuary_Bio @roslynvchand Is there a term for this purgatory? The $ESPR curse perhaps? 12:12am |
 |
@MarcJacksonLA $ESPR Esperion Therapeutics Shares Hit 52-Week Low After Public Offering Prices https://t.co/YAsYKFxPBW 12:12am |
 |
@Jarvis_Alerts $ESPR 12.5C Exp:20-Jan-23 ? ? Total(Day): $50,000 #UnusualActivity Sign-up free for beta ver.:… https://t.co/qP7PgSwY3v December 3rd 2021, 10:12pm |
 |
@mediasentiment $ESPR new alert at https://t.co/A7qrDarJHY #stocks #daytrading #NYSE #NASDAQ #market 869 December 3rd 2021, 9:12pm |
 |
@_B_I_O_T_E_C_H_ Goldman Sachs lower $ESPR PT to $5 and reiterate Sell https://t.co/saoMXT4dY5 December 3rd 2021, 8:12pm |
 |
@BPrasad93 @RealTimeTradez Check out $ESPR https://t.co/TDa9jAW6DH December 3rd 2021, 8:12pm |
|
@BPrasad93 @sanglucci $ESPR DIAMOND HANDS OVER HERE BROTHA https://t.co/Hl3WWjjK4O December 3rd 2021, 8:12pm |
|
@mediasentiment $ESPR new alert at https://t.co/A7qrDarJHY #stocks #daytrading #NYSE #NASDAQ #market 836 December 3rd 2021, 8:12pm |
|
@mediasentiment $ESPR new alert at https://t.co/A7qrDarJHY #stocks #daytrading #NYSE #NASDAQ #market 835 December 3rd 2021, 8:12pm |
 |
@WALLSTREETODDS_ MOVES HAPPENING NOW (3:04pm) ? $ESPR is down 1.1% in the last 5 mins. ? There are 11 stocks that are up more tha… https://t.co/DmbHGEZtNh December 3rd 2021, 8:12pm |
|
@BPrasad93 @steve_papadakis $ESPR GONNA ROCKET NEXT WEEK https://t.co/aWI8d1jpSJ December 3rd 2021, 7:12pm |
|
@BPrasad93 @InvestorsLive Cost to borrow rising oversold one the news of a offering that closes in two days lol $ESPR https://t.co/GDLIdV8w2t December 3rd 2021, 7:12pm |
 |
@TradeWithAlerts A nice print for $ESPR at 2:37pm -- SIDE: Bid Click https://t.co/vVsu1HBCKO for more. Runners ?:… https://t.co/1kWgAzhZwf December 3rd 2021, 7:12pm |
 |
@askwarrenbuffet $ESPR will divulge plans for upcoming open market share buy back program, announcement pending… https://t.co/JJEDV5PoyM December 3rd 2021, 7:12pm |
 |
@tryingBot05 $ESPR($5.20) FINTEL showing the short side no shares to short and N/A for short interest https://t.co/qtOKfL54lT December 3rd 2021, 7:12pm |
 |
@TheAbubeker $ESPR they’re doing an offering of 220 millions and it’s almost lost half of its value ? WOW I guess it’s a good e… https://t.co/LtWDzvQbMG December 3rd 2021, 7:12pm |
 |
@AndreaAlbrigoni $ESPR what they shorting if only 100 shares available lmao ? https://t.co/hIPoXWbrN0 December 3rd 2021, 6:12pm |
|
@BPrasad93 @InvestorsLive Check out $ESPR big gap coming next week in the charts https://t.co/hK9gadlP5s December 3rd 2021, 6:12pm |
|
@BPrasad93 @TradesTrey @RobinhoodApp Check out $ESPR offering only for few days #rare to come across huge #gains #buythedip December 3rd 2021, 6:12pm |
 |
@ShogunTrade $ESPR Awaiting Buy Signal. Stock Trading Ideas by https://t.co/6vnULU2sSf https://t.co/up6JNHOkUu December 3rd 2021, 5:12pm |
|
@BPrasad93 @CrazySexyLola $ESPR LETS GOOOO December 3rd 2021, 5:12pm |
 |
@MaisaCorp $ESPR Each share of stock in the 32.1-million-share offering is being sold together with one short-term warrant to… https://t.co/iZvLmV9oj8 December 3rd 2021, 5:12pm |
 |
@Gambiste1 RT @Biohazard3737: When I spoke with $ESPR mgmt with stock @40, they were very adamant that they don't need to raise. Could have raised $22… December 3rd 2021, 5:12pm |
|
@Gambiste1 RT @XBIObserver: $ESPR is such a brutal tale. Now $5 a share and no end in sight https://t.co/cGfw06HTLF December 3rd 2021, 5:12pm |
|
@TradeWithAlerts A nice print for $ESPR at 12:22pm -- SIDE: BelowBid Click https://t.co/vVsu1HBCKO for more. Runners ?:… https://t.co/x4ZDeIrH9u December 3rd 2021, 5:12pm |
|
@BPrasad93 @squawksquare $ESPR #buyout underway Mr. Koenig was chief commercial officer at Portola Pharmaceuticals until the c… https://t.co/7YuL0eQjuf December 3rd 2021, 5:12pm |
 |
@vigtheapp $ESPR is on the move: -40.25%? ? Esperion Therapeutics shares are trading lower after the company priced a 32,142,8… https://t.co/WuFAwzCZpY December 3rd 2021, 5:12pm |
|
@TradeWithAlerts A nice print for $ESPR at 12:11pm -- SIDE: Bid Click https://t.co/vVsu1HBCKO for more. Runners ?:… https://t.co/U60GzBNGfY December 3rd 2021, 5:12pm |
|
@mediasentiment $ESPR new alert at https://t.co/A7qrDarJHY #stocks #daytrading #NYSE #NASDAQ #market 563 December 3rd 2021, 5:12pm |
|
@mediasentiment $ESPR new alert at https://t.co/A7qrDarJHY #stocks #daytrading #NYSE #NASDAQ #market 564 December 3rd 2021, 5:12pm |
|
@XBIObserver $ESPR is such a brutal tale. Now $5 a share and no end in sight https://t.co/cGfw06HTLF December 3rd 2021, 5:12pm |
 |
@Biohazard3737 When I spoke with $ESPR mgmt with stock @40, they were very adamant that they don't need to raise. Could have raise… https://t.co/Jmv0gpecer December 3rd 2021, 5:12pm |
 |
@KingsSaddle $ESPR Thinking about buying stock in DiDi Global, New Oriental Education, Longeveron, Carnival Corp, or Esperion Th… https://t.co/FsIoKNtFWF December 3rd 2021, 4:12pm |
 |
@Livetradeview1 $ESPR For a limited time, we are opening our trading chat-room. https://t.co/0bnRJkjkob December 3rd 2021, 4:12pm |
 |
@ThatUnl $ESPR Nice chart here.?? ? https://t.co/pEFvhHfskY December 3rd 2021, 4:12pm |
 |
@TeamRVRTrading $ESPR Nice chart here.?? https://t.co/BmUcKxHOUg December 3rd 2021, 4:12pm |
 |
@kaden_sytsma Entering a Long swing of $ESPR SHARES, mega gap down today, let’s diamond hand hold this bitty buying in at 5.40$ https://t.co/AMuBGvHSQl December 3rd 2021, 4:12pm |
|
@BPrasad93 @InvestorsLive $ESPR look most shit companies do a offering for a month or several weeks this company offering clos… https://t.co/S0Wej27YKM December 3rd 2021, 4:12pm |
|
@BPrasad93 @VolumePrintcess $ESPR look most shit companies do a offering for a month or several weeks this company offering cl… https://t.co/q0El0kI7BN December 3rd 2021, 4:12pm |
|
@BPrasad93 @AsennaWealth @elonmusk $ESPR look most shit companies do a offering for a month or several weeks this company offe… https://t.co/fQRRwbCVKN December 3rd 2021, 4:12pm |
 |
@mehabecapital Stocks in New Low today: $ESPR, Current Price: $5, Change today: -39.91%, Total Traded Volume: 11916187 https://t.co/Z3ESUiSHK8 December 3rd 2021, 4:12pm |
|
@mehabecapital Stocks in Top Losers today: $ESPR, Current Price: $5.46, Change today: -39.91%, Total Traded Volume: 11916187 https://t.co/dvHfz4TkKB December 3rd 2021, 4:12pm |
|
@mehabecapital $ESPR @ 5.37 (-40.52%) : Celyad Oncology, Longeveron leads healthcare gainers; Esperion Therapeutics, Biofrontera a… https://t.co/iEzzT44LvD December 3rd 2021, 4:12pm |
|
@BPrasad93 @canuck2usa Look at $ESPR honestly it’s super cheap due to this release which should be trading above at least $6 g… https://t.co/31qn0UU6B0 December 3rd 2021, 4:12pm |
|
@BPrasad93 @WOLF_Financial $ESPR TRADING AT A DEEP DISCOUNT https://t.co/VVaPu1Yvkq December 3rd 2021, 4:12pm |
|
@BPrasad93 @IncredibleTrade Exactly I’m in $ESPR TRADING AT DEEP VALUE #buythedip https://t.co/VVaPu1Yvkq December 3rd 2021, 4:12pm |
|
@BPrasad93 @jimcramer True but look at $ESPR undervalued charts dont lie #buythedip https://t.co/VVaPu1Yvkq December 3rd 2021, 4:12pm |
 |
@newsfilterio Esperion Shares Fall After $225M Capital Raise Via Equity $ESPR https://t.co/wzxXoZg0Nc December 3rd 2021, 4:12pm |
|
@TradeWithAlerts A nice print for $ESPR at 11:09am -- SIDE: Ask Click https://t.co/vVsu1HBCKO for more. Runners ?:… https://t.co/gkX8DErjx6 December 3rd 2021, 4:12pm |
DrugPatentWatch - Make Better Decisions
Contact © thinkBiotech LLC
2004 - 2021. All rights reserved.
DrugPatentWatch Video Training
Decision-making for generic drug entry and branded drug lifecycle management
By tracking patent expirations, patent litigation, generic and biosimilar development, you can anticipate these market-shaping forces and stay one step ahead.
This course answers the following questions to help you adapt:
- ✓ When will key drug patents expire?
- ✓ How can I find, evaluate, and plan for generic market entry opportunities?
- ✓ How can I find proprietary out-of-court settlements and deal terms?